EndoChoice’s Fuse System Earns FDA 510(k) Clearance, Increases Adenoma Detection by 71%

EndoChoice, Atlanta-based medical technology company focused on gastrointestinal diseases, has announced its Fuse System has recently received FDA 510(k) clearance.

Advertisement
Carrie Pallardy

Research has shown the Fuse System, three cameras attached to the end of an endoscope during colonoscopy procedures, to improve the detection rate of adenomas by 71 percent.

EndoChoice is displaying the Fuse System at Digestive Disease Week, held May 18 to 21 in Orlando, Fla.

More Articles on Gastroenterology:
Boston Scientific to Present Data at Digestive Disease Week
SAGES Appoints Dr. Gerald Fried President
PENTAX Launches Video Processor With PENTAX i-SCAN

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • 5 gastroenterologists in the headlines

    From new gastroenterology practices and specialty partnerships to workforce research, here are five gastroenterologists in recent Becker’s headlines:  1. Washington,…

    By: Francesca Mathewes

  • 5 of the largest GI groups to know

    Private equity and corporate buyers have turned gastroenterology into one of the most consolidated specialties in outpatient care.  Here are…

    By: Patsy Newitt
Advertisement

Comments are closed.